Global Mycoplasma Testing Market Professional Survey Report 2019

The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.
The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

The global Mycoplasma Testing market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Mycoplasma Testing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mycoplasma Testing market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mycoplasma Testing in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mycoplasma Testing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
PCR
ELSA
Enzymatic Methods
DNA Staining

Segment by Application
Cell Line Testing
Virus Testing